Colombia issues a compulsory license on patents for the HIV drug Dolutegravir
Access to Medicine
Transparency mandate embedded into the proposed amendments to the International Health Regulations: Rationales underpinning the proposed Bureau’s text
On 17 April 2024, the World Health Organization (WHO) published the Proposed Bureau’s text in advance of the 8th meeting of the Working Group on Amendments to the International Health Regulations (2005) (WGIHR) which meets from 22–26 April 2024. Accompanying… Continue Reading
The Article 13 Express: WHA 77.1 – WHO Pandemic Agreement
On Wednesday, 17 April 2024 at 15:25 CEST, the WHO secretariat circulated an advance, unedited English version of the proposed draft WHO Pandemic Agreement; the WHO secretariat also circulated the accompanying draft resolution, WHA77.1 WHO Pandemic Agreement. For KEI’s analysis… Continue Reading
KEI comments on the 16 April 2024 draft of the WHO Pandemic agreement
On Friday, 19 April 2024, Knowledge Ecology International (KEI) published these comments on the 16 April 2024 draft of the WHO Pandemic agreement. KEIcomment16April2024draftWHOpandemictreaty The 16 April 2024 text (A/INB/9R/3, Proposal for the WHO Pandemic Agreement) can be found here:… Continue Reading
Colombia’s birthday present to the World Trade Organization: a proposal to review the implementation of the TRIPS Agreement: Article 71.1
On 15 April 2024, the World Trade Organization (WTO) published a document, IP/C/W/712, entitled, Review of the implementation of the TRIPS Agreement: Article 71.1; this date marks 30 years after the establishment of the WTO. Colombia’s proposal can be found… Continue Reading
Request for CMS to provide a Bayh-Dole Section 202 license and a 28 USC 1498 authorization and consent to use three patents listed in the FDA Orange Book for the cancer drug enzalutamide
Letter from KEI, UACT and UAEM to Chiquita White Brooks-Lasure, Administrator of the Office of the Administrator, Centers for Medicare and Medicaid Services, at HHS, asking that CMS to provide a Bayh-Dole Section 202 license and a 28 USC 1498… Continue Reading
KEI Comments to the NIH on Exclusive License to UK Firm Poolbeg Pharma
On April 8, 2024, Knowledge Ecology International (KEI) submitted comments to the National Institutes of Health (NIH) regarding the prospective grant of an exclusive license to Poolbeg Pharma Limited, a UK-based company. The license concerns, “Adoptive T Cell Therapy Products… Continue Reading
The WHO pandemic treaty: The Peace Clause and its discontents
On Tuesday, 2 April 2024, Politico published the onscreen text WHO pandemic treaty text of Wednesday, 27 March 2024; the time stamp of this 110 page text is 12:44 CET. Article 11 of the proposed agreement contains provisions on transfer… Continue Reading
INB9: KEI written statement
INB 9 Written statement by Knowledge Ecology International 28 March 2024 Transparency The negotiations on a WHO pandemic agreement should be more transparent. The negotiating texts with attributed country positions should be public and the meetings should be webcast. These… Continue Reading
WTO General Council (March 2024): Colombia’s intervention on TRIPS for Development: Post MC13 work on TRIPS-related Issues – Communication from Bangladesh, Colombia, Egypt and India
On Friday, 22 March 2024, Ambassador Mauricio Alberto Bustamante Garcia, Permanent Mission of Colombia to the World Trade Organization (WTO) delivered the following statement at the WTO General Council in relation to the submission by Bangladesh, Colombia, Egypt, and India… Continue Reading